Prostate-specific targeting using PSA promoter-based lentiviral vectors-Reference-Cited by-同舟云学术

Prostate-specific targeting using PSA promoter-based lentiviral vectors

Published:2001-09 Issue:9 Volume:8 Page:628-635
ISSN:0929-1903
Container-title:Cancer Gene Therapy
language:en
Short-container-title:Cancer Gene Ther

Author:

Yu Duan,Chen Dalin,Chiu Chris,Razmazma Babak,Chow Yen-Hung,Pang Shen

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/7700344.pdf

Reference39 articles.

1. Soderdahl DW, Wettlaufer JN, Corn B, Gomella LG . Neoadjuvant hormonal therapy in the management of prostate cancer: a surgical and radiation therapy review Tech Urol 1996 2: 194–206

2. Ismail M, Gomella LG . Current treatment of advanced prostate cancer Tech Urol 1997 3: 16–24

3. Fournier G . Treatment of hormone-refractory prostate carcinoma Eur Urol 1996 30: 32–37

4. Klotz L . Hormone therapy for patients with prostate carcinoma Cancer 2000 88: 3009–3014

5. Oh WK, Kandoff PW . Management of hormone refractory prostate cancer: current standards and future prospects J Urol 1998 160: 1220–1229

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polymeric nanoparticles for dual-targeted theranostic gene delivery to hepatocellular carcinoma;Science Advances;2022-07-22

2. Pseudotyped lentiviral vectors: Ready for translation into targeted cancer gene therapy?;Genes & Diseases;2022-04

3. Lentiviral mediated gene delivery as an effective therapeutic approach for Parkinson disease;Neuroscience Letters;2021-04

4. Targeted Diphtheria Toxin-Based Therapy: A Review Article;Frontiers in Microbiology;2019-10-18

5. Beyond the biomarker role: prostate-specific antigen (PSA) in the prostate cancer microenvironment;Cancer and Metastasis Reviews;2019-09